The Gross Margin of Endonovo Therapeutics Inc (ENDV) is 92.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | 92.62% |
| 2021-12-31 | 79.50% |
| 2020-12-31 | 60.57% |
| 2019-12-31 | 69.89% |
| 2018-12-31 | 84.47% |
| 2017-12-31 | 49.41% |
| 2016-12-31 | 35.97% |
| 2015-12-31 | 38.91% |